Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
A cross-sectional study of hpv vaccine acceptability in gaborone, botswana
PLoS ONE, Volume 6, No. 10, Article e25481, Year 2011
Notification
URL copied to clipboard!
Description
Background: Cervical cancer is the most common cancer among women in Botswana and elsewhere in Sub-Saharan Africa. We sought to examine whether HPV vaccine is acceptable among parents in Botswana, which recently licensed the vaccine to prevent cervical cancer. Methods and Findings: We conducted a cross-sectional survey in 2009, around the time the vaccine was first licensed, with adults recruited in general medicine and HIV clinics in Gaborone, the capital of Botswana. Although only 9% (32/376) of respondents had heard of HPV vaccine prior to the survey, 88% (329/376) said they definitely will have their adolescent daughters receive HPV vaccine. Most respondents would get the vaccine for their daughters at a public or community clinic (42%) or a gynecology or obstetrician's office (39%), and 74% would get it for a daughter if it were available at her school. Respondents were more likely to say that they definitely will get HPV vaccine for their daughters if they had less education (OR = 0.20, 95% CI = 0.07-0.58) or lived more than 30 kilometers from the capital, Gaborone (OR = 2.29, 95% CI = 1.06-4.93). Other correlates of acceptability were expecting to be involved in the decision to get HPV vaccine, thinking the vaccine would be hard to obtain, and perceiving greater severity of HPV-related diseases. Conclusions: HPV vaccination of adolescent girls would be highly acceptable if the vaccine became widely available to the daughters of healthcare seeking parents in Gaborone, Botswana. Potential HPV vaccination campaigns should provide more information about HPV and the vaccine as well as work to minimize barriers. © 2011 DiAngi et al.
Available Materials
https://efashare.b-cdn.net/share/pmc/articles/PMC3201944/bin/pone.0025481.s001.pdf
Authors & Co-Authors
DiAngi, Yumi Taylor
United States, Philadelphia
University of Pennsylvania
Panozzo, Catherine A.
United States, Chapel Hill
The University of North Carolina at Chapel Hill
Ramogola-Masire, D.
United States, Philadelphia
University of Pennsylvania
Botswana, Gaborone
University of Botswana
Steenhoff, Andrew P.
United States, Philadelphia
University of Pennsylvania
United States, Philadelphia
The Children's Hospital of Philadelphia
Brewer, Noel T.
United States, Chapel Hill
The University of North Carolina at Chapel Hill
Statistics
Citations: 71
Authors: 5
Affiliations: 4
Identifiers
Doi:
10.1371/journal.pone.0025481
e-ISSN:
19326203
Research Areas
Cancer
Health System And Policy
Infectious Diseases
Study Design
Cross Sectional Study
Study Approach
Quantitative
Study Locations
Botswana
Participants Gender
Female